Reduced fructosamine-3-kinase activity and its mRNA in human distal colorectal carcinoma

Genes and Nutrition

Volumn 5, Issue 3, 2010, Pages 257-262

  Notarnicola, M ^a   Caruso, Maria G ^a   Tutino, V ^a   Guerra, V ^a   Frisullo, S ^a   Altomare, D F ^b   Misciagna, G ^a  

^a NATIONAL INSTITUTE FOR DIGESTIVE DISEASES   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Colorectal cancer; Fructosamine 3 kinase activity; Gene expression; Glycation

Indexed keywords

FRUCTOSAMINE; FRUCTOSAMINE 3 KINASE PROTEIN; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER TISSUE; CLINICAL ARTICLE; COLON MUCOSA; COLORECTAL CARCINOMA; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MALE; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RADIOMETRY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION;

EID: 77958084376     PISSN: 15558932     EISSN: 18653499     Source Type: Journal    
DOI: 10.1007/s12263-009-0165-y     Document Type: Article

References (28)

1. JW Baynes 1991 Role of oxidative stress in development of complications in diabetes Diabetes 40 405 412 10.2337/diabetes.40.4.405 2010041
2. V Bazan M Migliavacca I Zanna C Tubiolo S Corsale V Calo A Amato P Cammareri F Latteri N Grassi F Fulfaro R Porcasi V Morello RB Nuara G Dardanoni S Salerno MR Valerio L Dusonchet A Gerbino N Gebbia RM Tomasino A Russo 2002 DNA ploidy and S-phase fraction but not p53 or NM23-HI expression predictoutcome in colorectal cancer patients. Result of a 5-year prospective study J Cancer Res Clin Oncol 128 650 658 10.1007/s00432-002-0394-6 12474051 (Pubitemid 35435840)
3. T Brown B Sut KA Brown MA Schwartz AM Tobia F Kappler 2003 Modulation of in vivo 3-deoxyglucosone levels Biochem Soc Trans 31 1433 1437 10.1042/BST0311433 14641082
4. M Brownlee 1994 Glycation and diabetic complications Diabetes 43 836 841 8194672
5. M Brownlee 2001 Biochemistry and molecular cell biology of diabetic complications Nature 414 813 820 10.1038/414813a 11742414 (Pubitemid 34000785)
6. MG Caruso M Notarnicola DF Altomare G Misciagna 2007 Gene expression of Fructosamine 3-Kinase in patients with colorectal cancer Oncology 73 72 75 10.1159/000120631 18334852 (Pubitemid 351465603)
7. MG Caruso M Notarnicola M Bifulco C Laezza V Guerra DF Altomare V Memeo D Lorusso I Demma A Di Leo 2003 Increased farnesyltransferase activity in human colorectal cancer: relationship with clinicopathological features and K-ras mutation Scand J Gastroenterol 38 80 85 10.1080/00365520310000483 12608469 (Pubitemid 36152869)
8. G Delpierre E Van Schaftigen 2003 Fructosamine3-kinase, an enzyme involved in protein deglycation Biochem Soc Trans 31 1354 1357 10.1042/BST0311354 14641062
9. G Delpierre D Vertommen D Communi H Rider E Van Schaftigen 2004 Identification of fructosamine residues deglycated by fructosamine-3-kinase in human hemoglobin J Biol Chem 279 27613 27620 10.1074/jbc.M402091200 (Pubitemid 38812603)
10. J Fortpied P Maliekal D Vertommen E Van Schaftigen 2006 Magnesium-dependent phosphatase-1 is a protein-fructosamine-6-phosphatase potentially involved in glycation repair J Biol Chem 281 18378 18385 10.1074/jbc.M513208200 16670083 (Pubitemid 44035495)
11. E Kapiteijn GJ Liefers LC Los E Kranenbarg J Hermans RAEM Tollenaar Y Moriya CJH van de Velde JHJM van Krieken 2001 Mechanisms of oncogenesis in colon versus rectal cancer J Pathol 195 171 178 10.1002/path.918 11592095 (Pubitemid 32899025)
12. H Kuniyasu Y Chihara T Takahashi 2003 Co-expression of receptor for advanced glycation and products and the ligand amphoterin associate closely with metastasis of colorectal cancer Oncol Rep 10 445 448 12579287
13. F-y Li M Lai 2009 Colorectal cancer, one entity or three J Zhejiang Univ Sci B 10 3 219 229 10.1631/jzus.B0820273 19283877
14. C Messa A Russo MG Caruso A Di Leo 1998 EGF, TGF-α and EGF-R in human colorectal adenocarcinoma Acta Oncol 37 285 289 10.1080/028418698429595 9677101 (Pubitemid 28307854)
15. G Misciagna G De Michele V Guerra AM Cisternino A Di Leo JL Freudenheim INTEROSP Group 2004 Serum fructosamine and colorectal adenomas Eur J Epidemiol 19 425 432 10.1023/B:EJEP.0000027359.95727.24 15233314 (Pubitemid 39012755)
16. VM Monnier 2005 Bacterial enzymes that can deglycate glucose-and fructose-modified lysine Biochem J 392 e11 e13
17. VM Monnier 2006 The fructosamine 3 Kinase knockout mouse: a tool for testing the glycation hypothesis of intracellular protein damage in diabetes and aging Biochem J 399 e11 e13 10.1042/BJ20061232 16987105
18. M Notarnicola C Messa M Pricci V Guerra D Altomare S Montemurro MG Caruso 2004 Up-regulation of 3-hydroxy-3-methylglutaryl coenzyme a reductase activity in left sided human colon cancer Anticancer Res 24 3837 3842 15736419
19. SW Oh YH Kim YS Choi DK Chang HJ Son PL Rhee JJ Kim JC Rhee SH Yun WY Lee HK Chun DH Kim SG Shim 2008 The comparison of the risk factors and clinical manifestations of proximal and distal colorectal cancer Dis Colon Rectum 51 1 56 61 10.1007/s10350-007-9083-5 18030529
20. M Peppa SA Raptis 2008 Advanced glycation end products and cardiovascular disease Curr Diab Rev 4 2 92 100 10.2174/157339908784220732
21. T Sasahira Y Akama K Fujii H Kuniyasu 2005 Expression of receptor for advanced glycation end products and HMGB1/amphoterin in colorectal adenomas Virchow Archiv 446 411 415 10.1007/s00428-005-1210-x (Pubitemid 40674848)
22. M Shinohara PJ Thornalley I Giardino P Beisswenger S Thorpe J Onorato M Brownlee 1998 Overexpression of glyoxalase I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis J Clin Invest 101 1142 1147 10.1172/JCI119885 9486985
23. A Siddiqui SJ Spechler S Huerta S Dredar BB Little B Cryer 2008 Elevated HbA1c is an independent predictor of aggressive clinical behaviour in patients with colorectal cancer: a case-control study Dig Dis Sci 53 9 2486 2494 10.1007/s10620-008-0264-4 18409001
24. A Smit H Lutgers 2004 The clinical relevance of advanced glycation endproducts (AGE) and recent developments in pharmaceutics to reduce AGE accumulation Curr Med Chem 11 2767 2784 15544475
25. BS Szwergold S Howell PJ Beisswenger 2001 Human fructosamine-3-kinase: purification, sequencing, substrate specificity and evidence of activity in vivo Diabetes 50 2139 2147 10.2337/diabetes.50.9.2139 11522682
26. E Van Schaftigen G Delpierre F Collard J Fortpied R Gemayel E Wiame M Veiga-da-Cunha 2007 Fructosamine 3 kinase and other enzymes involved in protein deglycation Adv Enzyme Regul 47 261 269 10.1016/j.advenzreg.2006.12.002 (Pubitemid 47302076)
27. S Yamagishi K Nakamura H Inoue S Kikuchi M Takeuchi 2005 Possible participation of advanced glycation end products in the pathogenesis of colorectal cancer in diabetic patients Med Hypotheses 64 1208 1210 10.1016/j.mehy.2005.01.015 15823719
28. S Yamagishi S Ueda S Okuda 2007 Food-derived advanced glycation end products (AGEs): a novel therapeutic target for various disorders Curr Pharm Des 13 27 2832 2836 10.2174/138161207781757051 17897026 (Pubitemid 350130976)